Hynalubone Injection (Sodium Hyaluronate) (Pre-filled)

Adult administration

Administer 25mg of sodium hyaluronate once a week for 5 consecutive weeks into the intra-articular space of the knee or shoulder joint, but the frequency of administration should be adjusted according to symptoms. This drug is administered intra-articularly, so it must be done under strict aseptic conditions.

This drug is administered intra-articularly and should not be used in patients with a known allergy to this drug or its components. This drug should not be administered if there are skin diseases or infections in the joint area. Caution is required when administering this drug to patients with liver dysfunction or a history of liver disease. While administering, allergic reactions or shock may occur, so patients should be closely monitored, and administration should be immediately stopped with appropriate treatment if any unusual symptoms arise. Transient pain, swelling, redness, warmth, etc., may occur at the injection site, so patients should inform healthcare professionals if these symptoms occur. Before administration, if there is severe inflammation in the joint, it is advisable to treat the inflammation first before using this drug. After administration, stabilize the joint and avoid vigorous exercise or prolonged weight-bearing activities for safety. The safety and effectiveness of this drug have not been confirmed when used with other intra-articular injections, so they should not be used together. Women who are pregnant or may become pregnant should use this drug with caution, and breastfeeding mothers should avoid breastfeeding after administration. The safety of this drug in children has not been established, so special care is needed. Elderly patients may have reduced physical function, so caution is required during administration. This drug must be administered in a sterile condition, and intravenous injection is strictly prohibited. A needle of appropriate gauge must be used for viscous solutions, and the ampoule should be shaken to mix the solution well. After use, the needle should be disposed of immediately and not reused; it is recommended to use a local anesthetic before administering this drug.

Serious side effects

Shock

Mild side effects

Swelling (facial, eyelid, etc.), facial flushing, rash, urticaria, itching, pain (mainly transient pain after administration), swelling, redness, warmth, localized severe pressure sensation, petechiae, nausea, vomiting, fever, headache

This drug should be stored in a sealed container to prevent air or moisture from entering, and it is important to maintain a storage temperature between 1 and 30 degrees Celsius. Storing it this way will safely maintain the effectiveness of the drug.

Appearance

An injection filled with a colorless, transparent, viscous liquid contained in a colorless, transparent glass syringe closed at both ends with a rubber stopper (part of the pre-filled syringe system).

Package unit

10 pre-filled syringes per box [2.5ml/pre-filled syringe * 10]